Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Povidone-iodine + chlorhexidine gluconate is a combination of two powerful antiseptic agents used for skin preparation before surgical procedures and other medical interventions. This combination leverages the complementary mechanisms of action of both antiseptics to potentially enhance antimicrobial efficacy. Research indicates that the sequential or concurrent use of these antiseptics may provide superior antimicrobial activity compared to either agent alone. Studies have shown that this combination leads to greater reduction in aerobic and anaerobic bacterial burden on the skin and within surgical sites, potentially resulting in lower rates of surgical site infections and intravascular catheter colonization. The combination works through chlorhexidine's persistent antimicrobial activity against a broad spectrum of microorganisms and povidone-iodine's rapid bactericidal effect. While traditionally these agents were used separately due to concerns about potential incompatibility, research has demonstrated that they can be used together effectively without reducing their antimicrobial properties.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on povidone-iodine + chlorhexidine gluconate.